Carmel, IN, March 1, 2002. A double blind, placebo controlled, cross over study of thirty osteoarthritic patients switched from non-steroidal anti-inflammatory drug (NSAID's) therapies to the Boswellia Serrata Extract (BSE) of Salki Guggul (Cap Wokvel, manufactured by Pharmanza India) found a significant decrease in severity of pain and swelling.
Patients received 333 mg of BSE per capsule, in the dose of one capsule three times a day, for 8 weeks. All patients reported decrease in knee pain, increased knee flexion, increased walking distance, improvement in capacity of climbing stairs, better ability in kneeling, crossed legged sitting and squatting. The knee range of movement was improved. The frequency of swelling in the knee joint was decreased.
Geni Inc will be presenting the full study at Vitafoods, May 14th at 2pm. Geni anticipates the study to be published early May. The overwhelming response has led Geni to sponsor further clincial studies on Boswellia and other Ayurvedic botanicals.
Geni Inc supplies and manufactures Ayurvedic herbs, standardized extracts, nutraceuticals, and GMO free soy products. For more information please visit www.GeniHerbs.com or call 317.587.8818.